SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-003145
Filing Date
2017-03-31
Accepted
2017-03-31 14:00:42
Documents
64
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2198811
2 ex21.htm EX-21 2426
3 ex23-1.htm EX-23.1 5793
4 ex31-1.htm EX-31.1 17972
5 ex31-2.htm EX-31.2 17249
6 ex32.htm EX-32 8480
  Complete submission text file 0001493152-17-003145.txt   9868776

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE rspi-20161231.xml EX-101.INS 1527054
8 XBRL SCHEMA FILE rspi-20161231.xsd EX-101.SCH 107194
9 XBRL CALCULATION FILE rspi-20161231_cal.xml EX-101.CAL 61907
10 XBRL DEFINITION FILE rspi-20161231_def.xml EX-101.DEF 435163
11 XBRL LABEL FILE rspi-20161231_lab.xml EX-101.LAB 725979
12 XBRL PRESENTATION FILE rspi-20161231_pre.xml EX-101.PRE 518999
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16467 | Film No.: 17729616
SIC: 2834 Pharmaceutical Preparations